Biosimilars: US FDA Developing Guidance For First Interchangeable Exclusivity
First Interchangeable Biosimilar Approved Is Entitled To One Year Of Exclusivity
First interchangeable exclusivity guidance is one of several the FDA is writing in the interchangeability area • Source: Shutterstock 
